This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2003 Jul 9;290(2):256-8.

doi: 10.1001/jama.290.2.256.

Unraveling severe sepsis: why did OPTIMIST fail and what's next?

Derek C Angus, Mark A Crowther

PMID: 12851282
DOI: 10.1001/jama.290.2.256

Editorial

Unraveling severe sepsis: why did OPTIMIST fail and what's next?

Derek C Angus et al. JAMA. 2003.

. 2003 Jul 9;290(2):256-8.

doi: 10.1001/jama.290.2.256.

Authors

Derek C Angus, Mark A Crowther

PMID: 12851282
DOI: 10.1001/jama.290.2.256

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.
Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettilä V, Sprung CL, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA; OPTIMIST Trial Study Group. Abraham E, et al. JAMA. 2003 Jul 9;290(2):238-47. doi: 10.1001/jama.290.2.238. JAMA. 2003. PMID: 12851279 Clinical Trial.

Similar articles

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.
Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettilä V, Sprung CL, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA; OPTIMIST Trial Study Group. Abraham E, et al. JAMA. 2003 Jul 9;290(2):238-47. doi: 10.1001/jama.290.2.238. JAMA. 2003. PMID: 12851279 Clinical Trial.
[Clinical trials for severe sepsis/DIC].
Kushimoto S. Kushimoto S. Rinsho Byori. 2011 Feb;Suppl 147:85-94. Rinsho Byori. 2011. PMID: 21761754 Japanese. No abstract available.
[Activated protein C (the impact of PROWESS trial)].
Iba T, Kidokoro A. Iba T, et al. Nihon Rinsho. 2004 Dec;62(12):2296-300. Nihon Rinsho. 2004. PMID: 15597799 Clinical Trial. Japanese.
Emerging therapies in severe sepsis.
Finney SJ, Evans TW. Finney SJ, et al. Thorax. 2002 Oct;57 Suppl 2(Suppl 2):II8-II14. Thorax. 2002. PMID: 12364705 Free PMC article. Review. No abstract available.
[Anticoagulation in the treatment of sepsis. Correction of microcirculation: a new approach manipulating endothelial cell function].
Kujath P, Bouchard R, Shekarriz H, Eckmann C. Kujath P, et al. Chirurg. 2002 Nov;73(11):1093-9. doi: 10.1007/s00104-002-0553-y. Chirurg. 2002. PMID: 12430059 Review. German.

See all similar articles

Cited by

Imaging Lymphoid Cell Death In Vivo During Polymicrobial Sepsis.
Zou L, Chen HH, Li D, Xu G, Feng Y, Chen C, Wang L, Sosnovik DE, Chao W. Zou L, et al. Crit Care Med. 2015 Nov;43(11):2303-12. doi: 10.1097/CCM.0000000000001254. Crit Care Med. 2015. PMID: 26335111 Free PMC article.
Trials stopped early for benefit? Not so fast!
Heffner AC, Milbrandt EB, Venkataraman R. Heffner AC, et al. Crit Care. 2007;11(1):305. doi: 10.1186/cc5676. Crit Care. 2007. PMID: 17338836 Free PMC article. No abstract available.
Scientific and clinical challenges in sepsis.
Ulloa L, Brunner M, Ramos L, Deitch EA. Ulloa L, et al. Curr Pharm Des. 2009;15(16):1918-35. doi: 10.2174/138161209788453248. Curr Pharm Des. 2009. PMID: 19519432 Free PMC article. Review.
Recently published papers: curing, caring and follow-up.
Williams G. Williams G. Crit Care. 2003 Oct;7(5):339-41. doi: 10.1186/cc2381. Epub 2003 Sep 2. Crit Care. 2003. PMID: 12974962 Free PMC article. Review. No abstract available.
A randomized clinical trial of unfractioned heparin for treatment of sepsis (the HETRASE study): design and rationale [NCT00100308].
Jaimes F, De la Rosa G, Arango C, Fortich F, Morales C, Aguirre D, Patiño P. Jaimes F, et al. Trials. 2006 May 26;7:19. doi: 10.1186/1745-6215-7-19. Trials. 2006. PMID: 16729879 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information